撤回：一种用于预测透明细胞肾细胞癌患者预后不良的新型生物标志物FKBP10 。
Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.
作者信息
And Alternative Medicine Evidence-Based Complementary
出版信息
Evid Based Complement Alternat Med. 2023 Oct 4;2023:9780837. doi: 10.1155/2023/9780837. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/5490644.].
摘要
[本文撤回文章DOI: 10.1155/2022/5490644。]
相似文献
1
Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.撤回：一种用于预测透明细胞肾细胞癌患者预后不良的新型生物标志物FKBP10 。
Evid Based Complement Alternat Med. 2023 Oct 4;2023:9780837. doi: 10.1155/2023/9780837. eCollection 2023.
2
A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.一种用于预测透明细胞肾细胞癌患者预后不良的新型生物标志物FKBP10
Evid Based Complement Alternat Med. 2022 Jun 10;2022:5490644. doi: 10.1155/2022/5490644. eCollection 2022.
3
Retracted: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.撤回：人透明细胞肾细胞癌中E2F的表达与预后综合分析
J Healthc Eng. 2022 Nov 27;2022:9807439. doi: 10.1155/2022/9807439. eCollection 2022.
4
Retracted: A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.撤回：一种基于胆固醇生物合成相关基因的新生存模型用于透明细胞肾细胞癌的预后预测
Biomed Res Int. 2024 Mar 20;2024:9838460. doi: 10.1155/2024/9838460. eCollection 2024.
5
Retracted: Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma.撤回：肾透明细胞癌患者中差异表达的铁死亡相关基因筛选及预后模型构建
Comput Math Methods Med. 2023 Oct 18;2023:9823636. doi: 10.1155/2023/9823636. eCollection 2023.
6
Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/-Catenin Pathway.撤回：NEK2作为一种新型生物标志物，通过激活WNT/β-连环蛋白信号通路增强透明细胞肾细胞癌的致瘤性。
Evid Based Complement Alternat Med. 2023 Jul 12;2023:9876715. doi: 10.1155/2023/9876715. eCollection 2023.
7
Retracted: Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma.撤回：肾透明细胞癌中LINC00472调控网络的综合分析。
J Healthc Eng. 2023 Oct 4;2023:9864232. doi: 10.1155/2023/9864232. eCollection 2023.
8
Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma.撤稿：血浆白细胞介素-35升高作为局限性透明细胞肾细胞癌的预后指标
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9846548. doi: 10.1155/2023/9846548. eCollection 2023.
9
Retracted: A Nomogram Predicting the Prognosis of Renal Cell Carcinoma Patients with Lung Metastases.撤回：预测肾细胞癌肺转移患者预后的列线图
Biomed Res Int. 2023 Nov 29;2023:9832720. doi: 10.1155/2023/9832720. eCollection 2023.
10
Retracted: Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.撤回：RNA结合蛋白在透明细胞肾细胞癌中的作用及其预后价值的综合分析
J Healthc Eng. 2023 May 24;2023:9828737. doi: 10.1155/2023/9828737. eCollection 2023.
本文引用的文献
1
A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.一种用于预测透明细胞肾细胞癌患者预后不良的新型生物标志物FKBP10
Evid Based Complement Alternat Med. 2022 Jun 10;2022:5490644. doi: 10.1155/2022/5490644. eCollection 2022.
Zotero 插件